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Wednesday, February 11, 2015 513awe have proposed the dynamical event and plausible mechanism of complex
formation of Gal3p and Gal1p with Gal80p at the molecular level.
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PED/PEA-15 (phosphoprotein enriched in diabetes/astrocytes, 15 kD) is a
small, non-catalytic, death-effector domain (DED) containing protein, that is
widely expressed in different tissues and highly conserved among mammals.
PED/PEA-15 has been found to interact with several protein targets in various
pathways, including FADD and procaspase-8 (apoptosis), ERK1/2 (cell cycle
entry), and PLD1/2 (diabetes). We have previously reported a surprising
conformational change of PED/PEA-15 DED upon interaction with ERK2 us-
ing NMR dynamics and residual dipolar coupling (RDC) data. In the complex,
PED/PEA-15 utilizes helices a1, a5, and a6 of the DED, in addition to the C-
terminal tail, to binding to ERK2, while helices a2, a3, and a4 are highly flex-
ible in the complex, and adopt a distinct relative orientation comparing to the
free-form conformation. We have additionally modeled the PED/PEA-15 con-
formations in the ERK2 complex using CS/RDC-Rosetta protocol. Based on
our NMR model of PED/PEA-15 complex with ERK2, we propose that the
conserved charge triad motif on DED surface, comprising of D19-R72-
D74L, which is located at a hinge position between these two dynamically
distinct segments, mediates the necessary conformational changes to accom-
modate ERK2 binding. We believe that various conformations of the DED,
facilitated by large number of surface polar interactions, may attribute to its
ability to interact with structurally and functionally diverse proteins.
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The Class A G-protein coupled receptor, GPR18, is a newly de-orphanized
cannabinoid receptor that binds the endogenous ligand, N-arachidonoyl glycine
(NAGly). As part of a larger project to model the interaction of ligands with
GPR18, we undertook the conformational analysis of NAGly. Because
NAGLY is an arachidonic acid derivative and arachidonic acid has been shown
to be highly flexible, we began by investigating the conformational flexibility
of this endogenous ligand. To this end, the Conformational Memories (CM)
method was employed. This method combines Monte Carlo exploration of
the dihedral angle and bond angle space with simulated annealing (MC/SA)
to determine the range of values that each dihedral angle and bond angle is
capable of exploring in a broad temperature range (Whitnell J Comp Chem
2007). Similar to previously reported CM results for arachidonic acid (Bar-
nett-Norris J Med Chem 1998), NAGly’s conformers could be divided into
four groups: linear, U-shape, J-shape, and helical. These results will be used
to explore the binding site interactions of NAGly at GPR18.
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Apicomplexan pathogens present significant health and economic burdens
globally. Species of Plasmodium, the causative agent of malaria, result in
more than half a million deaths annually, with the primary victims being chil-
dren under the age of five. Other organisms in this phylum present a threat to
immunocompromised individuals (e.g., Toxoplasma gondii, Cryptosporidium
spp.) or to the productivity of the livestock industry (e.g., Eimeria spp., Neo-
spora caninum). Autophagy is the process by which cells recycle intracellular
material by encapsulating them in a double membrane bound vesicle, the auto-
phagosome, which then fuses with the lysosome. The autophagy pathway has
been shown to be essential to parasite survival in both Plasmodium and Toxo-
plasma. Autophagy-related protein 8 (Atg8), which is required for the forma-
tion of the autophagosomal membrane, is a ubiquitin-like protein whose
conjugation pathway is conserved in Apicomplexa. Within Apicomplexans,
Atg8 has a conserved loop region not present in human homologues. In Plas-
modium falciparum, this loop was shown to be essential to the interaction be-
tween Atg8 and its E2 conjugating enzyme, Atg3, and may represent a viable
pan-Apicomplexan drug target. We are pursuing this possibility using x-ray
crystallography, SPR, and virtual library screening to identify small compound
drug leads which can then be chemically diversified and optimized. Havingsolved the structure of PfAtg8, we performed two screens against this protein:
a screen of the MMV Malaria box of compounds and a virtual library screen.
We pursued hits from both screens and tested them via SPR against five pairs
of Atg3 and Atg8 homologues: Plasmodium falciparum, Homo sapiens, Cryp-
tosporidium parvum, Eimeria tenella, and Neospora caninum. We have now
also obtained protein crystals for the Atg8 homologues in E. tenella,C. parvum,
and N. caninum, which will facilitate future virtual library screens against these
specific proteins.
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We have used time-resolved EPR and fluorescence to resolve structural transi-
tions of dystrophin upon actin binding. Dystrophin (Dys) is a muscle cytoskel-
etal protein that binds to filamentous actin (F-actin) and the dystroglycan
complex in the sarcolemmal membrane. Dys acts to dissipate mechanical forces
generated during the contraction and relaxation of muscle thereby maintaining
sarcolemmal membrane integrity and protecting from tears. The protein-protein
interactions and allostery underlying this function of Dys have not been well
studied in the context of conformational change and thermodynamics, partly
because acquisition of structural and thermodynamic detail on large and flex-
ible proteins is difficult. Two techniques capable of measuring large-scale
conformational changes are dipolar electron-electron resonance (DEER) and
time-resolved fluorescence resonance energy transfer (TR-FRET). Using a
combination of DEER and TR-FRET, we placed a single label (nitroxide
or fluorescent) in each CH domain Dys ABD1 and subsequently measured
the interprobe distance to assess conformational change upon association
with F-actin. To probe the allosteric network of Dys ABD1, we also subjected
the protein to differential scanning calorimetry.
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Lipocalin-type Prostaglandin D synthase (L-PGDS) catalyzes the isomeriza-
tion of prostaglandin H2 (PGH2) to produce prostaglandin D2 (PGD2), which
acts as a somnogen in the brain. This enzyme belongs to the lipocalin super-
family which consists of transporter proteins for lipophilic substances in the
extracellular space. Our previous studies suggested that L-PGDS is comprised
of a b-barrel structure with a hydrophobic pocket and the active thiol group of
Cys65 is located in this pocket and faces the inside of the pocket. A number
of studies of L-PGDS, as a drug target for treating sleep disorders, have been
reported, in attempts to understand its catalytic mechanism, and several sub-
strate recognition models of L-PGDS have been proposed. However, details
of the mechanism by which L-PDGS recognizes its substrates and products
are obscure, since essential information, such as its binding affinity and stoi-
chiometry of the interactions between L-PGDS and its substrate and product
remains unclear. To address this, the binding properties of the molecule were
examined by isothermal titration calorimetry (ITC) and NMR experiments.
The results of the ITC measurements revealed that, not only the substrate
analog, but also the product bind to L-PGDS in a stoichiometry of 2 to 1
and that L-PGDS possesses two binding sites (high and low affinity sites).
In addition, NMR titration and ITC experiments of L-PGDS mutants indi-
cated that the active Cys65 residue is located at the high affinity-binding
site and plays a critical role in the binding of the substrate and product to
L-PGDS.
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Protein-protein interactions are vital to the proper functioning of numerous bio-
logical systems. Thrombomodulin (TM) is a protein that is involved in the
down-regulation of coagulation induced by the clotting protein thrombin. Com-
plement component 3 (C3) is a vital component of the complement system,
which is involved in innate immunity against bacteria and viruses. However,
dysregulation of C3 can lead to the degradation of host cells. Evidence suggests
that the lectin-like domain of TM (TMD1) may interact with active C3 (C3b) to
inactivate it, thus preventing host cell degradation. The research conducted
